SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -58.1% | 498 | -49.8% | 0.00% | -100.0% |
| Q1 2023 | $136 | +18.3% | 992 | +11.2% | 0.00% | 0.0% |
| Q4 2022 | $115 | -100.0% | 892 | -83.1% | 0.00% | -66.7% |
| Q3 2022 | $581,000 | +159.4% | 5,276 | +75.6% | 0.00% | +200.0% |
| Q2 2022 | $224,000 | -56.1% | 3,005 | -47.1% | 0.00% | -50.0% |
| Q4 2021 | $510,000 | -17.3% | 5,683 | -15.0% | 0.00% | 0.0% |
| Q3 2021 | $617,000 | +116.5% | 6,684 | +75.0% | 0.00% | +100.0% |
| Q1 2021 | $285,000 | +917.9% | 3,819 | +2107.5% | 0.00% | – |
| Q2 2020 | $28,000 | – | 173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |